Markets · 1 sources covering this

Derivatives Trading Sinks at Biggest Indian Bourse on RBI Curbs

India’s largest stock exchange was severely hit by the central bank’s tighter funding rules implemented last month, with spending on derivatives slumping to a 17-month low.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

BloombergLean L·3h ago
Derivatives Trading Sinks at Biggest Indian Bourse on RBI Curbs
India’s largest stock exchange was severely hit by the central bank’s tighter funding rules implemented last month, with spending on derivatives slumping to a 17-month low.
Read at Bloomberg →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/6501fa1a4c4ea670ddf133dea875af0bf7a2cbc6"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Derivatives Trading Sinks at Biggest Indian Bourse on RBI Curbs"></iframe>

Derivatives Trading Sinks at Biggest Indian Bourse on RBI Curbs

How 1 sources are covering this

Derivatives Trading Sinks at Biggest Indian Bourse on RBI Curbs

More from Markets

Gold is still in its ‘explosive phase,’ says Deutsche Bank, as it sticks to year-end target

Chile Peso Bonds Face Pressure if Strait of Hormuz Stays Closed

Nigeria’s Top Bank Offers $1 Billion Shares Held by Bridge Firm

An AstraZeneca, Bristol Myers Squibb merger could create a cancer-drug giant, but analysts call it ‘odd’

Reader

Trust & legal

Across the network

How 1 sources are covering this

Derivatives Trading Sinks at Biggest Indian Bourse on RBI Curbs

More from Markets

Gold is still in its &#x2018;explosive phase,&#x2019; says Deutsche Bank, as it sticks to year-end target

Chile Peso Bonds Face Pressure if Strait of Hormuz Stays Closed

Nigeria’s Top Bank Offers $1 Billion Shares Held by Bridge Firm

An AstraZeneca, Bristol Myers Squibb merger could create a cancer-drug giant, but analysts call it &#x2018;odd&#x2019;

Reader

Trust & legal

Across the network

Gold is still in its ‘explosive phase,’ says Deutsche Bank, as it sticks to year-end target

An AstraZeneca, Bristol Myers Squibb merger could create a cancer-drug giant, but analysts call it ‘odd’